Last reviewed · How we verify
Lactobacillus Plantarum 299v
Lactobacillus Plantarum 299v is a Small molecule drug developed by Medical University of Bialystok. It is currently FDA-approved. Also known as: Lp 299v.
Lactobacillus Plantarum 299v, marketed by the Medical University of Bialystok, is a probiotic with a well-established presence in the market. The key composition patent is set to expire in 2028, providing a significant period of exclusivity and potential revenue protection. The primary risk lies in the lack of detailed clinical trial results and revenue data, which may limit investor confidence and market expansion efforts.
At a glance
| Generic name | Lactobacillus Plantarum 299v |
|---|---|
| Also known as | Lp 299v |
| Sponsor | Medical University of Bialystok |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of Probiotic Supplementation on Endothelial Function II (NA)
- Lactiplantibacillus Plantarum 299v Probiotic Supplementation in Patients With Diabetic Macular Edema (PHASE2)
- Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females (PHASE2)
- Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant (PHASE3)
- Pilot Study Lp299v Supplementation in Chronic Heart Failure (NA)
- Vascular Aging and Lp299v Study (NA)
- Impact of Lp299v on Vascular Function in Patients With PASC (NA)
- Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain in Nephrology and Transplantation Department (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lactobacillus Plantarum 299v CI brief — competitive landscape report
- Lactobacillus Plantarum 299v updates RSS · CI watch RSS
- Medical University of Bialystok portfolio CI
Frequently asked questions about Lactobacillus Plantarum 299v
What is Lactobacillus Plantarum 299v?
Who makes Lactobacillus Plantarum 299v?
Is Lactobacillus Plantarum 299v also known as anything else?
What development phase is Lactobacillus Plantarum 299v in?
Related
- Manufacturer: Medical University of Bialystok — full pipeline
- Also known as: Lp 299v